New eye drug BBC1501 enters first human safety trial for blinding disease
Disease control
Recruiting now
This early-stage trial tests an experimental drug called BBC1501, given as an injection into the eye, for people with wet age-related macular degeneration (nAMD). The main goal is to check safety and tolerability in 18 volunteers aged 50 and older who have already received standa…
Phase: PHASE1 • Sponsor: Benobio Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC